Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha

American Journal of the Medical Sciences

Volumn 341, Issue 6, 2011, Pages 504-507

  Krysiak, Robert ^a   Boldys, Aleksandra ^a   Okopien, Boguslaw ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adrenal cortex insufficiency; Autoimmune polyglandular syndromes; Hypothyroidism; Interferon ; Premature ovarian failure

Indexed keywords

CLADRIBINE; FLUDROCORTISONE; HYDROCORTISONE; LEVOTHYROXINE; ORAL CONTRACEPTIVE AGENT; PEGINTERFERON ALPHA; PENTOSTATIN; TETRACOSACTIDE;

ADDISON DISEASE; ADRENAL CORTEX INSUFFICIENCY; ADULT; AMENORRHEA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; CASE REPORT; COLD INTOLERANCE; CONSTIPATION; DEHYDRATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; DYSPNEA; FATIGUE; FEMALE; GYNECOLOGICAL EXAMINATION; HAIR LOSS; HAIRY CELL LEUKEMIA; HUMAN; HYPERTENSION; HYPOTHYROIDISM; LABORATORY TEST; MENSTRUAL IRREGULARITY; MUSCLE CRAMP; NEUROENDOCRINE DISEASE; ORAL CONTRACEPTION; PHYSICAL EXAMINATION; PREMATURE OVARIAN FAILURE; REMISSION; RISK FACTOR; SIDE EFFECT; TACHYCARDIA; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 79958086556     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31820ff7af     Document Type: Article

References (16)

1. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010;6:270-7.
2. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
3. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syn-dromes (APS). Acta Biomed 2003;74:9-33. (Pubitemid 36850394)
4. Betterle C, Lazzarotto F, Presotto F. Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 2004;137: 225-33. (Pubitemid 39013066)
5. Betterle C, Dalpra C, Greggio N, et al. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2 and 4. Ann Endocrinol 2001;62:193-201.
6. Kahaly GJ. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009;161:11-20.
7. Tomer Y, Menconi F. Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab 2009;23:703-2.
8. Andrade LJ, Atta AM, D'Almeida Junior A, et al. Thyroid dysfunc-tion in hepatitis C individuals treated with interferon-alpha and ribavi-rin\a review. Braz J Infect Dis 2008;12:144-8.
9. Sasso FC, Carbonara O, Di Micco P, et al. A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy. Br J Clin Pharmacol 2003;56:238-9. (Pubitemid 36981442)
10. Fujioka T, Honda M, Yoshizaki T, et al. A case oftype 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-alpha plus ribavirin treatment for chronic hepatitis C. Intern Med 2010;49:1987-90.
11. Kötter I, Hamuryudan V, Oztürk ZE, et al. Interferon therapy in rheumatic diseases: state-of-the-art 2010. Curr Opin Rheumatol 2010; 22:278-83.
12. Husebye E, Løvås K. Pathogenesis ofprimary adrenal insufficiency Best Pract Res Clin Endocrinol Metab 2009;23:147-57.
13. Betterle C, Dal Pra C, Mantero F, et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibod-ies, autoantigens, and their applicability in diagnosis and disease pre-diction. Endocr Rev 2002;23:327-64. (Pubitemid 34651950)
14. Lipsett MB. Factors influencing the rate of metabolism of steroid hormones in man. Ann N Y Acad Sci 1971;179:442-9.
15. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency Lancet 2010;376:911-21.
16. Mattle V, Behringer K, Engert A, et al. Female fertility after cytotoxic therapy\protection of ovarian function during chemotherapy ofmalignant and non-malignant diseases. Eur J Haematol Suppl 2005; 66:77-82. (Pubitemid 40873982)